European Equities Traded in the US as American Depositary Receipts Fall Sharply in Friday Trading

European equities traded in the US as American depositary receipts were trending sharply lower Friday, falling 1.3% to 1,404.81 on the S&P Europe Select ADR Index, which is set to end the week down 1.

MT NewswiresJun 14 11:15 ET

European Equities Traded in the US as American Depositary Receipts Lower in Friday Trading

European equities traded in the US as American depositary receipts were heading lower late Friday morning, declining 0.49% to 1,445.71 on the S&P Europe Select ADR Index. Despite the decline, the inde

MT NewswiresJun 7 11:19 ET

European Equities Traded in the US as American Depositary Receipts Rise in Wednesday Trading

European equities traded in the US as American depositary receipts were higher Wednesday morning, rising 0.93% to 1,436.34 on the S&P Europe Select ADR Index. From continental Europe, the gainers were

MT NewswiresJun 5 11:10 ET

European Equities Traded in the US as American Depositary Receipts Trend Lower in Tuesday Trading

European equities traded in the US as American depositary receipts were trending lower late Tuesday morning, declining 0.61% to 1,415.12 on the S&P Europe Select ADR Index. From continental Europe, th

MT NewswiresJun 4 11:10 ET

TD Cowen Maintains Adaptimmune Therapeutics(ADAP.US) With Buy Rating

TD Cowen analyst Marc Frahm maintains $Adaptimmune Therapeutics(ADAP.US)$ with a buy rating.According to TipRanks data, the analyst has a success rate of 47.0% and a total average return of 23.7% over

moomoo NewsJun 4 08:31 ET

Adaptimmune to Present Data From Planned Interim Analysis of Pivotal IGNYTE-ESO Trial With Lete-cel at ASCO; Data Continue to Support Further Development of Sarcoma Franchise

Overall response rate of 40% consistent across sarcoma indications; median duration of response ~11 months with patients still in response at time of analysisInterim analysis data reinforces the poten

newsfileJun 3 12:00 ET